您的位置: 首页 > 农业专利 > 详情页

Dosing regimen for a selective S1P1 receptor agonist
专利权人:
ACTELION PHARMACEUTICALS LTD
发明人:
Patrick Brossard,Jasper Dingemanse,Oliver Nayler,Michael Scherz,Beat Steiner
申请号:
US14732013
公开号:
US10251867B2
申请日:
2015.06.05
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention relates to a dosing regimen for a selective S1P1 receptor agonist, whereby the selective S1P1 receptor agonist is administered to a subject in such a way that during the initial treatment phase the selective S1P1 receptor agonist is administered at a dose which induces desensitization of the heart wherein said dose is below the target dose, and at a dosing frequency that sustains desensitization of the heart, until no further acute heart rate reduction occurs, followed by dose up-titration to the target dose of the selective S1P1 receptor agonist.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充